Michael Hannus

Title: Michael Hannus: Innovator in RNA Interference and Infectious Disease Treatment

Introduction

Michael Hannus is a notable inventor based in Dresden, Germany. He has made significant contributions to the field of molecular medicine, particularly in the development of innovative methods for RNA interference and treatments for infectious diseases. With a total of 2 patents, his work has the potential to impact various medical applications.

Latest Patents

Hannus's latest patents include two groundbreaking inventions. The first patent, titled "High complexity siRNA pools," relates to a method for producing pools of siRNA molecules suitable for RNA interference. This invention aims to enhance the effectiveness of RNA-based therapies. The second patent, "Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases," focuses on the use of inhibitors of scavenger receptor class proteins, particularly ScarB1, for the production of a medicament aimed at treating and preventing infections involving liver and hematopoietic cells, such as malaria.

Career Highlights

Throughout his career, Michael Hannus has worked with several prestigious organizations. He has been associated with the Instituto de Medicina Molecular, the Faculty of Medicine at the University of Lisbon, and Cenix Bioscience GmbH. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Some of his notable coworkers include Cecilie Martin and Maria M Mota. Their collaborative efforts have further enriched the research environment and fostered innovation in their respective fields.

Conclusion

Michael Hannus is a distinguished inventor whose work in RNA interference and infectious disease treatment showcases his commitment to advancing medical science. His patents reflect a deep understanding of molecular mechanisms and a dedication to improving health outcomes.